A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease

NCT05956626 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
51
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Ocugen